Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway
Ye Lu, Wenshan Zhong, Yuanyuan Liu, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108504-108504
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 23
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
PD-1/PD-L1 axis in organ fibrosis
Youliang Zhao, Yaqian Qu, Changfu Hao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway
Hui Gong, Xing Lyu, Yang Liu, et al.
Life Sciences (2023) Vol. 334, pp. 122218-122218
Closed Access | Times Cited: 18
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis
Jie Tan, Qianfei Xue, Xiao Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies
Yue-Liang Yue, Mengyu Zhang, Jianyu Liu, et al.
Therapeutic Advances in Respiratory Disease (2022) Vol. 16
Open Access | Times Cited: 24
PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation
Qing Li, Mengsheng Deng, Rentao Wang, et al.
Pharmacological Research (2022) Vol. 187, pp. 106636-106636
Open Access | Times Cited: 21
Bioinformatics-based identification of mirdametinib as a potential therapeutic target for idiopathic pulmonary fibrosis associated with endoplasmic reticulum stress
Junwei Chen, Y. W. Du, Qi Yu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Aimin Jiang, Na Liu, Jingjing Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
The role of the PI3K/AKT/mTOR pathway in mediating PD-L1 upregulation during fibroblast transdifferentiation
Youliang Zhao, Yuanmeng Qi, Jiarui Xia, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113186-113186
Closed Access | Times Cited: 3
PD-1 immunology in the kidneys: a growing relationship
Ruyue Chen, Qiang Lin, Hanyun Tang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Overexpression of STX11 alleviates pulmonary fibrosis by inhibiting fibroblast activation via the PI3K/AKT/mTOR pathway
Guichuan Huang, Xiangsheng Yang, Qingyang Yu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
What role does PDL1 play in EMT changes in tumors and fibrosis?
Yun-Chao Zhang, Yuting Zhang, Yi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1
Yanliang Wu, Wen Shi, Haini Li, et al.
Phytomedicine (2023) Vol. 128, pp. 155318-155318
Closed Access | Times Cited: 5
PD-L1 dimerisation induced by biphenyl derivatives mediates anti-breast cancer activity via the non-immune PD-L1–AKT–mTOR/Bcl2 pathway
Hua Zhang, Shi-Jia Zhou, Chen-Feng Shen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Different Levels of Autophagy Activity in Mesenchymal Stem Cells Are Involved in the Progression of Idiopathic Pulmonary Fibrosis
Hongxia Tao, Qin Lv, Jing Zhang, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Involvement of PD-1+CD4+ T cells in the development of traumatic tracheal stenosis by regulating the IL-17/STAT3 pathway
Tingmei Feng, Wei Ji, Sheng Tan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167216-167216
Open Access | Times Cited: 1
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
Xiao Hu, Jin Ren, Qianfei Xue, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 5
Open Access | Times Cited: 3
Local Lung Fibroblast Autophagy in the Context of Lung Fibrosis Pathogenesis
Basheer Abdullah Marzoog
Current Respiratory Medicine Reviews (2022) Vol. 19, Iss. 1, pp. 6-11
Closed Access | Times Cited: 3
SMURF1-Interference Effects Autophagy and Pulmonary Fibrosis through SMAD7 and the TGF-β1/SMAD Pathway
Ligen Lin, Xue Dong, L.-M. Chen, et al.
Molecular Biology (2024) Vol. 58, Iss. 4, pp. 753-762
Closed Access
What Is on the Horizon for Treatments in Idiopathic Pulmonary Fibrosis?
Teng Moua, Misbah Baqir, Jay H. Ryu
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6304-6304
Open Access
Effect of FTY-720 on Pulmonary Fibrosis in Mice via the TGF-β1 Signaling Pathway and Autophagy
Yuying Jin, Weidong Liu, Ge Gao, et al.
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 4, pp. 434-445
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top